Cytostatic

... used as a drug needs an NDA approval before it can be marketed. The NCI is concerned with cancers, so its language was with reference to cytotoxic/cytostatic agents. The same applies to antibiotics or anti-inflammatory or cardiac drugs, but the NCI doesn't typically deal with these disease areas. ...

See entire post

... used as a drug needs an NDA approval before it can be marketed. The NCI is concerned with cancers, so its language was with reference to cytotoxic/cytostatic agents. The same applies to antibiotics or anti-inflammatory or cardiac drugs, but the NCI doesn't typically deal with these disease areas.

See entire post

(New Drug Application for cytotoxic/cytostatic agents or a Biologic License Application for biological agents) NDA for cytotoxic/cytostatic agents?

See entire post

... The formal process in the U.S. by which this occurs is the approval by FDA of a marketing application (New Drug Application for cytotoxic/cytostatic agents or a Biologic License Application for biological agents) submitted by a private firm; as noted previously, NCI does not submit NDAs ...

See entire post

... Germany Non-ribosomally synthesized peptides have compelling biological activities ranging from antimicrobial to immunosuppressive and from cytostatic to antitumor. The broad spectrum of applications in modern medicine is reflected in the great structural diversity of these natural products. ...

See entire post